US 11130783
CD40 targeted peptides and uses thereof
granted A61KA61K2239/31A61K31/436
Quick answer
US patent 11130783 (CD40 targeted peptides and uses thereof) held by Regents of the University of Minnesota expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2239/31, A61K31/436, A61K35/15, A61K35/39